OCAL APPLICATION OF HARIDRA AND DALCHINI LEPAIN BREASTPAI
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: R899- Unspecified abnormal finding in specimens from other organs, systems and tissues
- Registration Number
- CTRI/2020/12/029555
- Lead Sponsor
- DrDYPatil College of Ayurveda and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A) Patients with cyclic/ premenstrual mastalgia in premenstrual syndrome.
B) Mastalgia severe enough to disturb the life style of a woman.
C) Patients between menarche to menopause
Exclusion Criteria
A) Patients suffering from hyperprolcatinaemia.
B) Patients having history of or currently suffering from any malignancy, fibrocystic changes
and breast lump.
C) Antenatal patients and lactating mothers.
D) Patients with withdrawals of oral contraceptive pills.
E) Cyclic mastalgia with nodularity.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dalchini and haridra lepa in breast pain for local application and assessment at 0, 30, 60 and 90 daysTimepoint: Dalchini and haridra lepa in breast pain for local application and assessment at 0, 30, 60 and 90 days
- Secondary Outcome Measures
Name Time Method Dalchini and Haridra lepa is effective in Stanpeeda. Visual Analogue Scale for Breast Pain:A scale with 0 â?? 10 numeric ranking to measure the intensity of pain before treatment and <br/ ><br>after treatment to determine the efficacyTimepoint: 3 months (0, 30, 60 and 90 days)